Global Dialysis - Roche's antiviral meets main goal in late-stage study

Roche's antiviral meets main goal in late-stage study - Reuters

The study was designed to investigate whether extending therapy with Valcyte to 200 days from 100 days post-transplant will further reduce the incidence of ...